# Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers

> **NCT05965414** · EARLY_PHASE1 · COMPLETED · sponsor: **Artery Therapeutics, Inc.** · enrollment: 66 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** CS6253 Solution for Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05965414
- **Lead sponsor:** Artery Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-23
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2025-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05965414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05965414, "Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05965414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*